Impact of transfusion burden on health-related quality of life (HRQOL) and functioning in patients (pts) with myelofibrosis (MF): Post hoc analysis of SIMPLIFY-1 (S1) and -2 (S2).

Authors

Ruben Mesa

Ruben A. Mesa

Wake Forest University School of Medicine, Winston-Salem, NC

Ruben A. Mesa , Francesca Palandri , Srdan Verstovsek , Lucia Masarova , Claire Harrison , Flora Mazerolle , Boris Gorsh , Manal M'Hari , Zhaohui Wang , Catherine Elizabeth Ellis , Samineh Deheshi , Jun Kawashima , Robyn Von Maltzahn , Antoine Regnault

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders

Clinical Trial Registration Number

NCT01969838; NCT02101268

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 7066)

DOI

10.1200/JCO.2023.41.16_suppl.7066

Abstract #

7066

Poster Bd #

196

Abstract Disclosures

Similar Posters

First Author: Lucia Masarova

First Author: Ruben A. Mesa

First Author: Elliott F. Winton